Rapid Testing Enables Last-Minute HIV Prophylaxis
A CDC study finds rapid HIV testing with Oraquick to be well accepted, have high sensitivity and specificity, and be clinically useful among women of unknown serostatus presenting in labor.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)